Practice
Featured experience
Emerson $7.2 billion acquisition of remaining outstanding shares of AspenTech
We are advising Emerson on its acquisition
Intra-Cellular Therapies $14.6 billion acquisition by Johnson & Johnson
We are advising Intra-Cellular Therapies on the transaction
GSK up to $1.15 billion acquisition of IDRx
We are advising GSK on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Doma take-private acquisition by Title Resources Group
We are advising Doma on the transaction
Crane NXT $270 million acquisition of OpSec Security
We are advising Crane NXT on the acquisition
Sonae cash tender offer for Musti Group
We are advising Sonae on the tender offer
TASK Group Holdings AU$310 million acquisition by PAR Technology
We are advising TASK on the transaction
Mongolian Mining sale of 20% of Khangad Exploration
We are advising MMC on the transaction
TruArc Partners acquisition of Meyer Laboratory and $179 million financing
We advised TruArc Partners on the acquisition and related financing arrangements
Meritz Securities $500 million PIPE investment in Lotus Technology
We advised Meritz Securities on the transaction
Lightyear Capital strategic investment in Prime Pensions
We advised Lightyear Capital on the transaction and related debt financing
Alcoa $2.2 billion acquisition of Alumina
We are advising Alcoa on the acquisition
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition